Mangoceuticals, Inc. (MGRX) stock
MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
$0.15−0.03 (-16.22%)
Close on Nov 13, 2026Market cap $3.34MP/E –Yield –
Mangoceuticals total assets
Total assets on the balance sheet at the end of each period.
Mangoceuticals's total assets was $14.17M at Jun 30, 2026. For fiscal 2025 it was $16.09M, up 4.7% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.09M | +4.7% |
| FY2024 | Dec 31, 2024 | $15.37M | +1362.8% |
| FY2023 | Dec 31, 2023 | $1.05M | +4.7% |
| FY2022 | Dec 31, 2022 | $1.00M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $14.17M | -32.0% |
| Q1 FY2026 | Mar 31, 2026 | $14.45M | -33.6% |
| Q4 FY2025 | Dec 31, 2025 | $16.09M | +4.7% |
| Q3 FY2025 | Sep 30, 2025 | $16.53M | +11.8% |
| Q2 FY2025 | Jun 30, 2025 | $20.84M | +36.8% |
| Q1 FY2025 | Mar 31, 2025 | $21.75M | +7116.5% |
| Q4 FY2024 | Dec 31, 2024 | $15.37M | +1362.8% |
| Q3 FY2024 | Sep 30, 2024 | $14.79M | +827.1% |
| Q2 FY2024 | Jun 30, 2024 | $15.24M | +362.2% |
| Q1 FY2024 | Mar 31, 2024 | $301.45K | -92.7% |
| Q4 FY2023 | Dec 31, 2023 | $1.05M | +4.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.60M | – |
| Q2 FY2023 | Jun 30, 2023 | $3.30M | – |
| Q1 FY2023 | Mar 31, 2023 | $4.12M | – |
| Q4 FY2022 | Dec 31, 2022 | $1.00M | – |
See a number that looks wrong?